Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay
- 1 July 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 334 (2) , 202-210
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Mass spectrometry‐based proteomics: The road to lung cancer biomarker discoveryMass Spectrometry Reviews, 2012
- Monitoring the progression of metastatic breast cancer on nanoporous silica chipsPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2012
- Proteomics in Melanoma Biomarker Discovery: Great Potential, Many ObstaclesInternational Journal of Proteomics, 2011
- Decoding Melanoma MetastasisCancers, 2010
- A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serumExperimental Dermatology, 2010
- Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteinsNanoscale, 2010
- Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteomeProteomics, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Tailoring of the Nanotexture of Mesoporous Silica Films and Their Functionalized Derivatives for Selectively Harvesting Low Molecular Weight ProteinACS Nano, 2009
- Unwelcome ComplementCancer Research, 2009